Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
Back

Janet Englund, MD (she/her/hers)

Professor of Pediatrics
Seattle Children’s Hospital
Seattle, Washington, United States

Presentation(s):

  • How to Protect Children Around the World from Respiratory Syncytial Virus (RSV)

    Sunday, April 27, 2025
    10:45am – 12:15pm HST

    Disclosure(s): Abbvie (Terminated, July 1, 2023) (Products/Services: Consultant); Astra Zeneca (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Enanta (Ongoing) (Products/Services: Consultant); GlaxoSmithKline (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Merck (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Moderna (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness); Sanofi pasteur (Ongoing) (Products/Services: Consultant); Shionogi (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

  • Nirsevimab and RSV Vaccine Implementation in the U.S.: Achieving Universal Infant and Maternal Coverage

    Sunday, April 27, 2025
    10:45am – 11:05am HST

    Disclosure(s): Abbvie (Terminated, July 1, 2023) (Products/Services: Consultant); Astra Zeneca (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Enanta (Ongoing) (Products/Services: Consultant); GlaxoSmithKline (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Merck (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Moderna (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness); Sanofi pasteur (Ongoing) (Products/Services: Consultant); Shionogi (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)